Retrospective analysis: Consensus statement of the hypertension in African Americans working group of the International Society on Hypertension in Blacks (ISHIB)

Ethnicity and Disease

Volumn 15, Issue 1, 2005, Pages 3-5

  Ferdinand, Keith C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; AMLODIPINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LIPID; LISINOPRIL; LOSARTAN; METOPROLOL; RAMIPRIL; RENIN; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; VALSARTAN; VERAPAMIL;

ADULT; AFRICAN AMERICAN; AGE; ALCOHOL WITHDRAWAL; ANAMNESIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EDITORIAL; ENVIRONMENTAL FACTOR; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; LIFESTYLE; MEDICAL SOCIETY; MENTAL DISEASE; META ANALYSIS; MICROALBUMINURIA; MONOTHERAPY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; SODIUM RESTRICTION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; EXERCISE; FOOD HABITS; HUMANS; HYPERTENSION; LIFE STYLE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 14644440795     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2466.
2. The ALLHAT Officers and Coordinators, for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2197.
3. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease; results from the AASK Trial. JAMA. 2002;288:2421-2431.
4. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719-2728.
5. Douglas JG, Bakris, GL, et al. Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525-541.